River Front Investment Group, LLC Vertex Pharmaceuticals Inc Transaction History

River Front Investment Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$181.39 - $202.99 $204,063 - $228,363	-1,125 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$187.49 - $221.1 $8,249 - $9,728	44 Added 4.07%	1,125 $227,000
Q1 2021 Apr 29, 2021	BUY	$207.02 - $241.31 $32,709 - $38,126	158 Added 17.12%	1,081 $232,000
Q4 2020 Feb 03, 2021	BUY	$207.01 - $276.09 $191,070 - $254,831	923 New	923 $218,000

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of River Front Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on River Front Investment Group, LLC with notifications on news.